Strategy

Baxdrostat gets FDA priority review

Read more

EU proposes rules to boost start-ups across Europe

Read more

Market barriers are obstacle to growth in EU

Read more

A business model for cell and gene therapies

Read more

How argenx reached Nasdaq as a small European biotech

Read more

Interview - How Abivax delivered results for patients with ulcerative colitis

Read more

Financial Strategy - Pricing innovative medicines in the UK

Read more

Mast cells could redefine metabolic disease treatment

Read more

Public Policy - The EU aims to be global hub for life sciences by 2030

Read more

DeepMind applies AI to genome analysis

Read more